Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

Journal of Clinical Investigation

Volumn 103, Issue 7, 1999, Pages 931-943

  Virkamäki, Antti ^a   Ueki, Kohjiro ^a   Kahn, C Ronald ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION; AUTOPHOSPHORYLATION; CELL COMPARTMENTALIZATION; COVALENT BOND; GENETIC TRANSCRIPTION; INSULIN BINDING; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 0042570843     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6609     Document Type: Review

References (168)

1. White, M.F. 1998. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182:3-11.
2. Sudol, M. 1998. From SRC homology domains to other signaling modules: proposal of the 'protein recognition code'. Oncogene. 17:1469-1474.
3. Yenush, L., et al. 1996. The pleckstrin homology domain is the principle link between the insulin receptor and IRS-1. J. Biol. Chem. 271:24300-24306.
4. Wolf, G., et al. 1995. The PTB domains of IRS-1 and Shc have distinct but overlapping specificities. J. Biol. Chem. 270:27407-27410.
5. Eck, M.J., Dhe-Paganon, S., Trub, T., Nolte, R.T., and Shoelson, S.E. 1996. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell. 85:695-705.
6. Pawson, T., Olivier, P., Rozakis-Adcock, M., McGlade, J., and Henkemeyer, M. 1993. Proteins with SH2 and SH3 domains couple receptor tyrosine kinases to intracellular signalling pathways. Philos. Trans. R. Soc. Lond. B Biol. Sci. 340:279-285.
7. Ebina, Y., et al. 1985. The human insulin receptor cDNA: the structural basis for hormone activated transmembrane signalling. Cell. 40:747-758.
8. Ullrich, A., et al. 1985. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature. 313:756-761.
9. Kasuga, M., Fujita-Yamaguchi, Y. Blithe, D.L., and Kahn, C.R. 1983. Tyrosine-specific protein kinase activity is associated with the purified insulin receptor. Proc. Natl. Acad. Sci. USA. 80:2137-2141.
10. White, M.F., et al. 1988. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell. 54:641-649.
11. Backer, J.M., Kahn, C.R., Cahill, D.A., Ullrich, A., and White, M.F. 1990. Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor β-subunit. J. Biol. Chem. 265:16450-16454.
12. Chen, W.J., Goldstein, J.L., and Brown, M.S. 1990. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J. Biol. Chem. 265:3116-3123.
13. Bansal, A. and Gierasch, L.M. 1991. The NPXY internalization signal of the LDL receptor adopts a reverse-turn conformation. Cell. 67:1195-1201.
14. Collawn, J.F., et al. 1990. Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis. Cell. 63:1061-1072.
15. Frattali, A.L., Treadway, J.L., and Pessin, J.E. 1992. Insulin/IGF-1 hybrid receptors: implications for the dominant- negative phenotype in syndromes of insulin resistance. J. Cell. Biochem. 48:43-50.
16. Van Horn, D.J., Myers, M.G., Jr., and Backer, J.M. 1994. Direct activation of the phosphatidylinositol 3′-kinase by the insulin receptor. J. Biochem. 269:29-32.
17. Sun, X.J., et al. 1992. The expression and function of IRS-1 in insulin signal transmission. J. Biol. Chem. 267:22662-22672.
18. Rothenberg, P.L., et al. 1991. Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase. J. Biol. Chem. 266:8302-8311.
19. Sun, X.J., et al. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature. 377:173-177.
20. Lavan, B.E., Lane, W.S., and Lienhard, G.E. 1997. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:11439-11443.
21. Lavan, B.E., et al. 1997. A novel 160 kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:21403-21407.
22. Holgado-Madruga, M., Emlet, D.R., Moscatello, D.K., Godwin, A.K., and Wong, A.J. 1996. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature. 379:560-563.
23. Pelicci, G., et al. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 70:93-104.
24. Carpino, N., et al. 1997. p62dok: a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell. 88:197-204.
25. Liu, F., and Roth, R.A. 1995. Grb-IR: a SH2 domain-containing protein that binds to the insulin receptor and inhibits its function. Proc. Natl. Acad. Sci. USA. 92:10287-10291.
26. c-src sre complexes and PI3-kinase. Cell. 65:91-104.
27. Antonetti, D.A., Algenstaedt, P., and Kahn, C.R. 1996. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol. Cell. Biol. 16:2195-2203.
28. Inukai, K., et al. 1997. p85α gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-kinase), p50α, p55α, and p85α, with different PI 3-kinase activity elevating responses to insulin. J. Biol. Chem. 272:7873-7882.
29. PIK reveals a new regulatory subunit for the phosphatidylinositol-3 kinase. Mol. Cell. Biol. 15:4453-4465.
30. Hara, K., et al. 1994. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for ras activation in CHO cells. Proc. Natl. Acad. Sci. USA. 91:7415-7419.
31. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., and Ui, M. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes: studies with a selective inhibitor wortmannin. J. Biol. Chem. 269:3568-3573.
32. Alessi, D.R. and Downes, C.P. 1998. The role of PI 3-kinase in insulin action. Biochim. Biophys. Acta. 1436:151-164.
33. Inoue, G., Cheatham, B., Emkey, R., and Kahn, C.R. 1998. Dynamics of insulin signaling in 3T3-L1 adipocytes: differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. J. Biol. Chem. 273:11548-11555.
34. Clark, S.F., Martin, S., Carozzi, A.J., Hill, M.M., and James, D.E. 1998. Intracellular localization of phosphatidylinositol 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement ofa membrane skeleton. J. Cell. Biol. 140:1211-1225.
35. Lowenstein, E.J., et al. 1992. The SH2 and SH3 domain-containing proteins GRB2 links receptor tyrosine kinases to ras signaling. Cell. 70:431-442.
36. Furman, W.L., et al. 1986. Antibodies to distal carboxyl terminal epitopes in the v-fms-coded glycoprotein do not cross-react with the c-fms gene product. Virology. 152:432-445.
37. Skolnik, E.Y., et al. 1993. The function of GRB2 in linking the insulin receptor to ras signaling pathways. Science. 260:1953-1955.
38. Myers, M.G., Jr., et al. 1994. The role of IRS-1/GRB2 complexes in insulin signaling. Mol. Cell. Biol. 14:3577-3587.
39. Tanaka, S., et al. 1994. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc. Natl. Acad. Sci. USA. 91:3443-3447.
40. Tanaka, S., Ouchi, T., and Hanafusa, H. 1997. Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G. Proc. Natl. Acad. Sci. USA. 94:2356-2361.
41. Mayer, B.J., Hamaguchi, M., and Hanafusa, H. 1988. A novel viral oncogene with structural similarity to phospholipase C. Nature. 332:272-275.
42. Sakai, R., et al. 1994. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13:3748-3756.
43. Matsuda, M., et al. 1996. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins. J. Biol. Chem. 271:14468-14472.
44. Beitner-Johnson, D., et al. 1996. The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. J. Biol. Chem. 271:9287-9290.
45. Lee, C.H., et al. 1993. Nek associates with the SH2 domain docking proteins IRS-1 in insulin stimulated cells. Proc. Natl. Acad. Sci. USA. 90:11713-11717.
46. Hu, Q., Milfay, D., and Williams, L.T. 1995. Binding of NCK to SOS and activation of ras-dependent gene expression. Mol. Cell. Biol. 15:1169-1174.
47. Quilliam, L.A., et al. 1996. Isolation of a NCK-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signaling. J. Biol. Chem. 271:28772-28776.
48. Bokoch, G.M., et al. 1996. Interaction of the Nek adapter protein with p21-activated kinase (PAK1). J. Biol. Chem. 271:25746-25749.
49. Sun, X.J., et al. 1996. The fyn tyrosine kinase binds IRS-1 and forms a distinct signaling complex during insulin stimulation. J. Biol. Chem. 271:10583-10587.
50. Mastick, C.C., and Saltiel, A.R. 1997. Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J. Biol. Chem. 272:20706-20714.
51. Liu, Y.C., and Altman, A. 1998. Cbl: complex formation and functional implications. Cell. Signal. 10:377-385.
52. Wary, K.K., Mariotti, A., Zurzolo, C., and Giancotti, F.G. 1998. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell. 94:625-634.
53. Ribon, V., Printen, J.A., Hoffman, N.G., Kay, B.K., and Saltiel, A.R. 1998. A novel, multifunctional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes. Mol. Cell. Biol. 18:872-879.
54. Ribon, V., Johnson, J.H., Camp, H.S., and Saltiel, A.R. 1998. Thiazolidinediones and insulin resistance: peroxisome proliferator activated receptor gamma activation stimulates expression of the CAP gene. Proc. Natl. Acad. Sci. USA. 95:14751-14756.
55. Liu, X., and Pawson, T. 1994. Biochemistry of the Src protein-tyrosine kinase: regulation by SH2 and SH3 domains. Recent Prog. Horm. Res. 49:149-160.
56. Tobe, K., et al. 1996. Csk enhances insulin-stimulated dephosphorylation of focal adhesion proteins. Mol. Cell. Biol. 16:4765-4772.
57. Baron, V., Calleja, V., Ferrari, P., Alengrin, F., and Van Obberghen, E. 1998. p125Fak focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-1 tyrosine kinase receptors. J. Biol. Chem. 273:7162-7168.
58. Cohen, P., Alessi, D.R., and Cross, D.A. 1997. PDK1, one of the missing links in insulin signal transduction? Growth Regul. 410:3-10.
59. Coffer, P.J., Jin, J., and Woodgett, J.R. 1998. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335:1-13.
60. Erneux, C., Govaerts, C., Communi, D., and Pesesse, X. 1998. The diversity and possible functions of the inositol polyphosphate 5-phosphatases. Biochim. Biophys. Acta. 1436:185-199.
61. Vollenweider, P., et al. 1999. An SH2 domain-containing 5′ inositol phosphatase inhibits insulin-induced GLUT4 translocation and growth factor-induced actin filament. Mol. Cell. Biol. 19:1081-1091.
62. Verdier, F., et al. 1997. Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation. J. Biol. Chem. 272:26173-26178.
63. Gale, N.W., Kaplan, S., Lowenstein, E.J., Schlessinger, J., and Bar-Sagi, D., 1993. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature. 363:88-92.
64. Xiao, S., et al. 1994. Syp(SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J. Biol. Chem. 269:21244-21248.
65. Noguchi, T., Matozaki, T., Horita, K., Fujioka, Y., and Kasuga, M. 1994. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated ras activation. Mol. Cell. Biol. 14:6674-6682.
66. Burbelo, P.D., and Hall, A. 1995. 14-3-3 proteins. Hot numbers in signal transduction. Curr. Biol. 5:95-96.
67. Yaffe, M.B., et al. 1997. The structural basis for 14-3-3 phosphopeptide binding specificity. Cell. 91:961-971.
68. Noguchi, T., et al. 1996. Characterization of a 115-kDa protein that binds to SH-PTP2, a protein tyrosine phosphatase with Src homology 2 domains, in Chinese hamster ovary cells. J. Biol. Chem. 271:27652-27658.
69. Ogihara, T., et al. 1997. 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J. Biol. Chem. 272:25267-25274.
70. Pipas, J.M. 1992. Common and unique features of T antigens encoded by the polyomavirus group. J. Virol. 66:3979-3985.
71. Zhou-Li, F., Xu, S.Q., Dews, M., and Baserga, R. 1997. Co-operation of simian virus 40T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal. Oncogene. 961-970.
72. Vuori, K., and Ruoslahti, E. 1994. Association of insulin receptor substrate-1 with integrins. Science. 266:1576-1578.
73. Zheng, B., and Clemmons, D.R. 1998. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA. 95:11217-11222.
74. Bruning, J.C., et al. 1998. A muscle specific insulin receptor knockout challenges the current concepts of glucose disposal and NIDDM pathogenesis. Mol. Cell. 2:559-569.
75. 2+-ATPases in muscle and heart. J. Biol. Chem. 272:23696-23702.
76. 2+ stores and atachidonic and metabolism. J. Clin. Invest. 101:1623-1632.
77. Kadowaki, T., et al. 1988. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science. 240:787-790.
78. Yoshimasa, Y., et al. 1988. Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Science. 240:784-787.
79. Krook, A., and O'Rahilly, S. 1996. Mutant insulin receptors in syndromes of insulin resistance [review]. Bailliers Clin. Enodrinol. Metab. 10:97-122.
80. Almind, K., et al. 1993. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 342:828-832.
81. Laakso, M., Malkki, M., Kekalainen, P., Kuusisto, J., and Deeb, S.S. 1994. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J. Clin. Invest. 94:1141-1146.
82. Ura, S., et al. 1996. Molecular scanning of the IRS-1 gene in Japanese patients with non-insulin-dependent diabetes mellitus: Identification of five novel mutations in IRS-1 gene. Diabetologia. 39:600-608.
83. Hager, J., Zouali, H., Velho, G., and Froguel, P. 1993. Insulin receptor substrate (IRS-1) gene polymorphism in French NIDDM families. Lancet. 342:1430.
84. Imai, Y., et al. 1994. Variant sequences of insulin receptor substrate-1 in patients with noninsulin dependent diabetes mellitus. J Clin. Endocrinol. Metab. 79:1655-1658.
85. Celi, F.S., et al. 1995. Lack of IRS-1 codon 513 and 972 polymorphism in Pima Indians. J. Clin. Endocrinol. Metab. 80:2827-2829.
86. Almind, K., Inoue, G., Pedersen, O., and Kahn, C.R. 1996. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J. Clin. Invest. 97:2569-2575.
87. Yoshimura, R., et al. 1997. Impact of natural IRS-1 mutations of insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling. Diabetes. 46:929-936.
88. Kalidas, K., et al. 1998. Mapping of the human insulin receptor substrate-2 gene, identification of a linked polymorphic marker and linkage analysis in families with Type 2 diabetes: no evidence for a major susceptibility role. Diabetologia. 41:1389-1391.
89. Almind, K., et al. 1998. Common amino acid substitutions in insulin receptor substrate-4 are not associated with Type II diabetes mellitus or insulin resistance. Diabetologia. 41:969-974.
90. Hansen, T., et al. 1997. Identification of a common amino acid polymorphism in the -85α regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness and the insulin sensitivity index. Diabetes. 46:494-501.
91. Spiegelman, B.M. 1998. PPARγ: adipogenic regulator and thiazolidinedione receptot. Diabetes. 47:507-514.
92. Ristow, M., Muller-Wieland, D., Pfeiffer, A., Krone, W., and Kahn, C.R 1998. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med. 339:953-959.
93. Deeb, S.S., et al. 1998. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 20:284-287.
94. Maddux, B.A., et al. 1995. Membrane glycoprotein PC-1 in the insulin resistance of non-insulin dependent diabetes mellitus. Nature. 373:448-451.
95. Goldfine, I.D., et al. 1998. Membrane glycoprotein PC-1 and insulin resistance. Mol. Cell. Biochem. 182:177-184.
96. Frittitta, L., et al. 1998. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in non-diabetic subjects: Evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Diabetes. 47:1095-1100.
97. Kumakura, S., Maddux, B.A., and Sung, C.K. 1998. Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site. J. Cell. Biochem. 3:366-377.
98. Youngren, J.F., et al. 1996. Skeletal muscle content of membrane glycoprotein pc-1 in obesity, relationship to muscle glucose transport. Diabetes. 10:1324-1328.
99. Reynet, C., and Kahn, C.R 1993. Rad: a member of the ras family overexpressed in muscle of type II diabetic humans. Science. 262:1441-1444.
100. Doria, A., et al. 1995. Trinucleotide repeats at the rad locus: allele distributions in NIDDM and mapping to a 3-cM region on chromosome 16q. Diabetes. 44:243-247.
101. Movers, J.S., Bilan, P.J., Reynet, C., and Kahn, C.R. 1996. Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells. J. Biol. Chem. 271:23111-23116.
102. Laville, M., et al. 1996. Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut4, and lipoprotein lipase mRNA levels in human muscle. J. Clin. Invest. 98:43-49.
103. Caro, J.F., et al. 1987. Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin-dependent diabetes. J. Clin. Invest. 79:1330-1337.
104. Olefsky, J.M. 1976. Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. J. Clin. Invest. 57:1165-1172.
105. Caro, J.F., et al. 1986. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. J. Clin. Invest. 78:249-258.
106. Freidenberg, G.R., Reichart, D.R., Olefsky, J.M., and Henry, R.R. 1988. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J. Clin. Invest. 82:1398-1406.
107. Hurrell, D.G., Pedersen, O., and Kahn, C.R. 1989. Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats. Endocrinology. 125:2454-2462.
108. Cremel, G., et al. 1993. Lipid modulation of insulin receptor tyrosine kinase activity in cultuted cells, animals, and reconstituted systems. Ann. NY Acad. Sci. 683:164-171.
109. Goodyear, L.J., et al. 1995. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95:2195-2204.
110. Rondinone, C.M., et al. 1997. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA. 94:4171-4175.
111. Bjornholm, M., Kawano, Y., Lehtihet, M., and Zierath, J.R. 1997. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes. 46:524-527.
112. Zierath, J.R., Krook, A., and Wallberg-Henriksson, H. 1998. Insulin action in skeletal muscle from patients with NIDDM. Mol. Cell. Biochem. 182:153-160.
113. Friedman, J.E., et al. 1997. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am. J. Physiol. 273:E1014-E1023.
114. Anai, M., et al. 1998. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes. 47:13-23.
115. Kerouz, N.J., Horsch, D., Pons, S., and Kahn, C.R. 1997. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J. Clin. Invest. 100:3164-3172.
116. Hayakawa, T., Shiraki, T., Morimoto, T., Shii, K., and Ikeda, H. 1996. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats. Biochem. Biophys. Res. Commun. 223:439-444.
117. Folli, F., Saad, M.J.A., Becker, J.M., and Kahn, C.R. 1993. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J. Clin. Invest. 92:1787-1794.
118. Heydrick, S.J., Gautier, N., Olichon-Berthe, C. Van Obberghen, E. and Le Marchand-Brustel, Y. 1995. Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice. Am. J. Physiol. 268:E604-E612.
119. Hjollund, E., Pedersen, O., Richelsen, B., Beck-Nielsen, H. and Sorensen, N.S. 1985. Glucose transport and metabolism in adipocytes from newly diagnosed untreated insulin-dependent diabetics. Severely impaired basal and postinsulin binding activities. J. Clin. Invest. 76:2091-2096.
120. Pedersen, O. and Hjollund, E. 1982. Insulin receptor binding to fat and blood cells and insulin action in fat cells from insulin-dependent diabetics. Diabetes. 31:706-715.
121. Gerich, J.E. 1988. Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus. Diabetes. 37:1608-1617.
122. Reaven, G.M., Lithell, H., and Landsberg, L. 1996. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 334:374-381.
123. Ohsaka, Y., Tokumitsu, Y., and Nomura, Y. 1997. Suppression of insulin-stimulated phosphatidylinositol 3-kinase activity by the β3-adrenoceptor agonist CL316243 in rat adipocytes. Growth Regul. 402:246-250.
124. Green, A., Carroll, R.M., and Dobias, S.B. 1996. Desensitization of β-adrenergic receptors in adipocytes causes increased insulin sensitivity of glucose transport. Am. J. Physiol. 271:E271-E276.
125. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333:348-351.
126. 3-adrenoceptor agonist in human omental adipocytes. Diabetes. 48:117-120.
127. Hotamisligil, G.S., and Spiegelman, B.M. 1994. Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes. 43:1271-1278.
128. Peraldi, P. and Spiegelman, B. 1998. TNF-α and insulin resistance: summary and future prospects. Mol. Cell. Biochem. 182:169-175.
129. Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L., and Spiegelman, B.M. 1995. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95:2409-2415.
130. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. 1993. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 259:87-91.
131. Kanety, H., Feinstein, R., Papa, M.Z., Hemi, R., and Karasik, A. 1995. Tumor necrosis factor α-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J. Biol. Chem. 270:23780-23784.
132. Uysal, K.T., Wiesbrock, S.M., and Hotamisligil, G.S. 1998. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology. 139:4832-4838.
133. Zhang, Y., et al. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432.
134. Tartaglia, L.A. 1997. The leptin receptor. J. Biol. Chem. 272:6093-6096.
135. Sivitz, W.I., Walsh, S.A., Morgan, D.A., Thomas, M.J., and Haynes, W.G. 1997. Effects of leptin on insulin sensitivity in normal rats. Endocrinology. 138:3395-3401.
136. Kamohara, S., Burcelln, R., Halaas, J.L., Friedman, J.M., and Charron, M.J. 1997. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 389:374-377.
137. Shi, Z.Q., Nelson, A., Whitcomb, L., Wang, J., and Cohen, A.M. 1998. Intracerebroventricular administration of leptin markedly enhances insulin sensitivity and systemic glucose utilization in conscious rats. Metabolism. 47:1274-1280.
138. Poitout, V., Rouault, C., Guerte-Millo, M. and Reach, G. 1998. Does leptin regulate insulin secretion? Diabetes Metab. 24:321-326.
139. Rossetti, L., 1995. Glucose toxicicy: the implications of hyperglycemia in the pathophysiology of diabetes mellitus. Clin. Invest. Med. 16:255-260.
140. Vuorinen-Markkola, H., Koivisto, V.A., and Yki-Jarvinen, H. 1992. Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes. 41:571-580.
141. Yki-Jarvinen, H., Helve, E., and Koivisto, V.A. 1987. Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes. 36:892-896.
142. Rossetti, L., Smith, D., Shulman, G.I., Papachristou, D., and DeFronzo, R.A. 1987. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79:1510-1515.
143. McClain, D.A., and Crook, E.D. 1996. Hexosamines and insulin resistance. Diabetes. 45:1003-1009.
144. Rossetti, L., Hawkins, M., Chen, W., Gindi, J., and Barzilai, N. 1995. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J. Clin. Invest. 96:132-140.
145. Virkamaki, A., et al. 1997. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology. 138:2501-2507.
146. Hawkins, M., Angelov, I., Liu, R., Barzilai, N., and Rossetti, L. 1997. The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. J. Biol. Chem. 272:4889-4895.
147. Snow, D.M., and Hart, G.W. 1998. Nuclear and cytoplasmic glycosylation. Int. Rev. Cytol. 181:43-74.
148. Wang, J., Liu, R., Hawkins, M., Barzilai, N., and Rossetti, L. 1998. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature. 393:684-688.
149. Hebert, L.F., Jr., et al. 1996. Overexpression of glutamine: fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J. Clin. Invest. 98:930-936.
150. Marshall, S., Bacote, V., and Traxinger, R.R. 1991. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266:4706-4712.
151. Kim, Y.B., et al. 1999. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes. 48:310-320.
152. Newton, A.C. 1995. Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270:28495-28498.
153. Chen, K.S., Heydrick, S.J., Brown, M.L., Friel, J.C., and Ruderman, N.B. 1994. Insulin increases a biochemically distinct pool of diacylglycerol in the rat soleus muscle. Am. J. Physiol. 266:E479-E485.
154. Haring, H.U., et al. 1996. Modulation of insulin receptor signaling. Potential mechanisms of a cross talk between bradykinin and the insulin receptor [review]. Diabetes. 45(Suppl. 1):S115-S119.
155. Kellerer, M., and Haring, H.U. 1995. Pathogenesis of human resistance: modulation of the insulin signal at receptor level [review]. Diabetes Res. Clin. Pract. 28(Suppl.):S173-S177.
156. Kroder, G., et al. 1996. Tumor necrosis factor- and hyperglycemia-induced insulin resistance. J. Clin. Invest. 97:1471-1477.
157. Murphy, M., McGinty, A., and Godson, C. 1998. Protein kinases C: potential targets for intervention in diabetic nephropathy. Curr. Opin. Nephrol. Hypertens. 7:563-570.
158. Urano, T., Emkey, R., and Feig, L.A. 1996. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 15:810-816.
159. Ahmad, F., Azevedo, J., Cortright, R., Dohm, G.L., and Goldstein, B.J. 1997. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J. Clin. Invest. 100:449-458.
160. Goldstein, B.J., Ahmad, F., Ding, W., Li, P.M., and Zhang, W.R. 1998. Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases. Mol. Cell. Biochem. 182:91-99.
161. Accili, D., et al. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12:106-109.
162. Joshi, R.L., et al. 1996. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 15:1542-1547.
163. Araki, E., et al. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372:186-190.
164. Tamemoto, H., et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:182-186.
165. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-903.
166. Bruning, J.C., et al. 1997. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell. 88:561-572.
167. Kulkarni, R.N., et al. 1999. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in Type 2 diabetes. Cell. 96:329-339.
168. Ferrannini, E. 1998. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr. Rev. 19:477-490.